Literature DB >> 27882221

Overexpression of suppressor of IKBKE 1 is associated with vincristine resistance in colon cancer cells.

Chun-Peng Zhao1, Zhong-Jie Xu2, Qing Guo3, Yun-Xiao Li2, Xiang-Zheng Gao2, Yi-You Peng2.   

Abstract

In a previous study, the suppressor of IKBKE 1 expression level was confirmed to be higher in vincristine (VCR)-resistant HCT-8 (HCT-8/V) colon cancer cells than in non-VCR-resistant HCT-8 cells. In the current study, IKBKE 1 expression in VCR-resistant colon cancer cells was investigated further. HCT-8 and HCT-8/V human colon cancer cells were used, and polymerase chain reaction (PCR) primers were designed to amplify the IKBKE 1 gene. Fluorescence reverse transcription-quantitative PCR (RT-qPCR) was performed to detect differences in IKBKE 1 expression between sensitive and drug-resistant colon cancer cell lines. Western blotting was performed to further observe IKBKE 1 expression. Based on the RT-qPCR and western blot results, IKBKE 1 expression was observed to be markedly higher in the HCT-8/V cells, and this difference was significant (P<0.05). Thus, IKBKE 1 expression was identified to be associated with the resistance of colon cancer cells to VCR.

Entities:  

Keywords:  HCT-8; colon cancer; drug resistance; suppressor of IKBKE 1; vincristine

Year:  2016        PMID: 27882221      PMCID: PMC5103677          DOI: 10.3892/br.2016.759

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Molecular mechanism of increased sensitivity of cisplatin to ovarian cancer by inhibition of microRNA-23a expression.

Authors:  Ai-Hong Jin; Zhao-Lian Wei
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Comparison of chemotherapeutic drug resistance in cells transfected with canine ABCG2 or feline ABCG2.

Authors:  R S Lewis; J Fidel; S Dassanayake; M H Court; N S Burke; K L Mealey
Journal:  Vet Comp Oncol       Date:  2015-10-14       Impact factor: 2.613

Review 4.  Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?

Authors:  Tieu-Lan Chau; Romain Gioia; Jean-Stéphane Gatot; Félicia Patrascu; Isabelle Carpentier; Jean-Paul Chapelle; Luke O'Neill; Rudi Beyaert; Jacques Piette; Alain Chariot
Journal:  Trends Biochem Sci       Date:  2008-03-18       Impact factor: 13.807

5.  MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.

Authors:  F Akbari Moqadam; E A M Lange-Turenhout; I M Ariës; R Pieters; M L den Boer
Journal:  Leuk Res       Date:  2013-07-31       Impact factor: 3.156

6.  Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme.

Authors:  Amanda Tivnan; Zaitun Zakaria; Caitrín O'Leary; Donat Kögel; Jenny L Pokorny; Jann N Sarkaria; Jochen H M Prehn
Journal:  Front Neurosci       Date:  2015-06-16       Impact factor: 4.677

7.  Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer.

Authors:  Sang Ok Jung; Sun Young Kim; Ju-Ock Kim; Sung Soo Jung; Hee Sun Park; Jae Young Moon; Sung Min Kim; Jeong Eun Lee
Journal:  Thorac Cancer       Date:  2015-01-27       Impact factor: 3.500

8.  Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.

Authors:  Isabelle Bartram; Ulrike Erben; Jutta Ortiz-Tanchez; Katja Blunert; Cornelia Schlee; Martin Neumann; Sandra Heesch; Claudia D Baldus
Journal:  BMC Cancer       Date:  2015-10-08       Impact factor: 4.430

9.  The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo.

Authors:  Min-Wu Chao; Mei-Jung Lai; Jing-Ping Liou; Ya-Ling Chang; Jing-Chi Wang; Shiow-Lin Pan; Che-Ming Teng
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388

10.  Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.

Authors:  Zheng Wu; Zhe Zhang; Xiaoxiao Ge; Ying Lin; Congqi Dai; Jinjia Chang; Xinyang Liu; Ruixuan Geng; Chenchen Wang; Huan Chen; Menghong Sun; Weijian Guo; Jin Li
Journal:  Oncotarget       Date:  2015-12-01
View more
  3 in total

1.  Shikonin induces ROS-based mitochondria-mediated apoptosis in colon cancer.

Authors:  Wenquan Liang; Jianxin Cui; Kecheng Zhang; Hongqing Xi; Aizhen Cai; Jiyang Li; Yunhe Gao; Chong Hu; Yi Liu; Yixun Lu; Ning Wang; Xiaosong Wu; Bo Wei; Lin Chen
Journal:  Oncotarget       Date:  2017-11-17

Review 2.  Advances in IKBKE as a potential target for cancer therapy.

Authors:  Min Yin; Xin Wang; Jie Lu
Journal:  Cancer Med       Date:  2019-11-15       Impact factor: 4.452

3.  Tetramethylpyrazine inhibits proliferation of colon cancer cells in vitro.

Authors:  Hua Li; Yan-Xu Hou; Yu Yang; Qing-Qiang He; Tian-Hua Gao; Xiao-Feng Zhao; Zhi-Bin Huo; Shu-Bo Chen; Deng-Xiang Liu
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.